These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1688640)

  • 1. Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics.
    Campos L; Ffrench M; Guyotat D
    Leukemia; 1990 Jan; 4(1):60-2. PubMed ID: 1688640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple immunofluorescence evaluation of CD15, CD34 and class II expression by flow cytometry in normal and leukemic bone marrows.
    Venditti A; Del Poeta G; Stasi R; De Fabriitis P; Coppetelli U; Bruno A; Simone MD; Papa G
    Haematologica; 1993; 78(6):359-63. PubMed ID: 7513673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.
    Terstappen LW; Loken MR
    Anal Cell Pathol; 1990 Jul; 2(4):229-40. PubMed ID: 1703434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.
    Macedo A; Orfão A; Gonzalez M; Vidriales MB; López-Berges MC; Martínez A; San Miguel JF
    Leukemia; 1995 Jun; 9(6):993-8. PubMed ID: 7596191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid surface antigen expression in adult acute lymphoblastic leukemia.
    Guyotat D; Campos L; Shi ZH; Charrin C; Treille D; Magaud JP; Fiere D
    Leukemia; 1990 Sep; 4(9):664-6. PubMed ID: 1697640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
    Terstappen LW; Safford M; Könemann S; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1992 Jan; 6(1):70-80. PubMed ID: 1540262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56).
    Seymour JF; Pierce SA; Kantarjian HM; Keating MJ; Estey EH
    Leukemia; 1994 May; 8(5):823-6. PubMed ID: 7514247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
    Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
    Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
    Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
    Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of minimal residual disease in acute myeloid leukemia.
    Gerhartz HH; Schmetzer H
    Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
    Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
    Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
    Ericson SG; Colby E; Welch L; Ball ED
    Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
    Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S
    Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.